Locally Advanced Cervical Carcinoma Clinical Trials

8 recruiting

Locally Advanced Cervical Carcinoma Trials at a Glance

8 actively recruiting trials for locally advanced cervical carcinoma are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Shanghai, St Louis, and Leiden. Lead sponsors running locally advanced cervical carcinoma studies include RenJi Hospital, Washington University School of Medicine, and City of Hope Medical Center.

Browse locally advanced cervical carcinoma trials by phase

Treatments under study

About Locally Advanced Cervical Carcinoma Clinical Trials

Looking for clinical trials for Locally Advanced Cervical Carcinoma? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Locally Advanced Cervical Carcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Locally Advanced Cervical Carcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 1Phase 2

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+97 more
Mayo Clinic132 enrolled1 locationNCT05269381
Recruiting
Phase 1Phase 2

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

Locally Advanced Cervical Carcinoma
Washington University School of Medicine50 enrolled1 locationNCT06529809
Recruiting
Not Applicable

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial

Pancreatic CancerCervical CancerLocally Advanced Cervical Carcinoma+7 more
Washington University School of Medicine60 enrolled1 locationNCT05975593
Recruiting
Phase 2

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Malignant Solid NeoplasmLocally Advanced Cervical CarcinomaRecurrent Prostate Carcinoma+15 more
City of Hope Medical Center60 enrolled1 locationNCT05722288
Recruiting

Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

Locally Advanced Cervical Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS129 enrolled1 locationNCT06398938
Recruiting
Phase 1Phase 2

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

Locally Advanced Cervical CarcinomaImmunotherapyConcurrent Chemoradiotherapy
RenJi Hospital20 enrolled1 locationNCT06391190
Recruiting

the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer

Locally Advanced Cervical CarcinomaImmunotherapyConcurrent Chemoradiotherapy
RenJi Hospital20 enrolled1 locationNCT06378840
Recruiting
Not Applicable

PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer

Uterine Cervical NeoplasmsLocally Advanced Cervical Carcinoma
Leiden University Medical Center30 enrolled2 locationsNCT05406856